文献速递类风湿关节炎其他结缔组织病

验证基于理赔数据识别类风湿关节炎相关间质性肺病的算法

Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis.
PubMed 文献 · Semin Arthritis Rheum · 2020-05-20

本研究利用2012至2014年Medicare理赔数据链接电子病历,在5,214例类风湿关节炎(RA)患者中开发并验证了8种基于理赔的间质性肺病(ILD)识别算法,以胸部CT或肺活检为金标准。结果显示,要求专科医生(呼吸科或风湿科)至少2次ILD诊断编码的算法阳性预测值(PPV)最高,达72.4%,支持在大规模行政理赔数据中识别RA-ILD队列。

要点

  • 专科医生≥2次ILD诊断编码的算法PPV达72.4%,优于其他算法。
  • 仅要求≥1次或≥2次任何医生诊断编码的算法PPV分别为43.4%和52.0%。
  • 增加操作编码(如影像、支气管镜)未提高PPV。

核心结论

  • 在RA患者中,要求专科医生≥2次ILD诊断编码的理赔算法识别ILD的PPV为72.4%。
  • 该算法支持利用大规模行政理赔数据识别基于人群的RA-ILD队列。

研究设计与样本

  • 使用2012至2014年Medicare理赔数据链接电子病历,纳入≥2次RA诊断编码且≥1种改善病情抗风湿药的患者。
  • 开发8种基于ICD-9诊断编码和操作编码的理赔算法,以胸部CT或肺活检确诊ILD为金标准评估PPV。

主要发现

  • 共纳入5,214例RA患者,各算法识别的ILD病例数为181至993例。
  • 基于诊断编码的算法PPV范围为43.4%(任何医生≥1次诊断编码)至52.0%(任何医生≥2次诊断编码)。
  • 要求≥1次操作编码(如影像、支气管镜)的算法PPV未提高。
  • 要求专科医生(呼吸科或风湿科)ILD诊断编码的算法PPV:≥1次编码为61.5%,≥2次编码为72.4%。

关键数值与推荐

  • RA患者定义:≥2次RA诊断编码且≥1种改善病情抗风湿药。
  • ILD金标准:胸部CT或肺活检确诊。
  • 最佳算法:专科医生≥2次ILD诊断编码,PPV 72.4%。

临床怎么用

  • 在利用行政理赔数据构建RA-ILD队列时,可优先采用要求专科医生≥2次ILD诊断编码的算法以提高识别准确性。
  • 仅使用诊断编码或增加操作编码要求可能不足以优化ILD识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop and validate claims-based algorithms to identify interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) METHODS: Using Medicare claims data linked with the electronic medical records (2012-2014), we first selected RA patients based on ≥2 diagnostic codes for RA and ≥1 disease-modifying antirheumatic drugs.Then, to identify ILD in RA, we developed eight claims-based algorithms using a combination of ICD-9 diagnosis codes and procedure codes related to the diagnosis or management of ILD. We assessed the positive predictive value (PPV) for each of the eight algorithms relative to confirmed ILD cases using chest computerized tomography or lung biopsy as the gold standard. RESULTS: A total of 5,214 RA patients were included in the study, and the ILD cases identified by each algorithm ranged from 181 to 993. The PPV of the diagnosis code-based algorithms ranged from 43.4% (≥1 diagnosis code by any physician) to 52.0% (≥2 diagnosis codes by any physician). When the algorithms further required ≥1 procedure code (e.g., imaging, bronchoscopy), the PPV did not improve. However, the algorithms that required ILD diagnosis codes by specialists (i.e., pulmonologist or rheumatologist) had PPVs of 61.5% with ≥1 code; 72.4% with ≥2 codes. CONCLUSIONS: In a cohort of RA patients, our algorithm that required ≥2 ILD diagnosis codes by specialists demonstrated a PPV of 72.4% in ascertaining ILD. Our results support the utility of the claims-based algorithm to identify a population-based cohort of RA patients with ILD using large administrative claims data.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Cho SK, Doyle TJ, Lee H, et al. Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2020. PMID: 32480097. doi:10.1016/j.semarthrit.2020.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。